Home > Search: Haldol Tablets

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Haldol Tablets All Topic Areas 1 - 10 of 314  more >> Haloperidol Tablets Haldol Tablets Haloperidol Lactate Injection Haldol Injection Haloperidol Decanoate Injection Haldol Decanoate Injection Haloperidol Oral Concentrate Haldol Oral Concentrate Carbinoxamine and Pseudoephedrine Tablets Coldec D Tablets Articles 1 - 1 of 1 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration News 1 - 5 of 184  more >> Actavis Launches Alprazolam ER Tablets In The U.S. MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST Tekturna(R) - The First New Type Of High Blood Pressure Medicine In More Than A Decade - Receives Its First Approval In The US MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST Lipitor Significantly Reduced The Risk Of Serious Cardiovascular Events Compared With Simvastatin In An 80,000-Patient AnalysisManage MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST Fish haters can get strong bones too Reuters - Fri, 23 Feb 2007 02:12 EST Drug Depot In A Tooth MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST Clinical Trials 1 - 5 of 118  more >> Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting Pain PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets ClinicalTrials.gov Identifier: NCT00491998 - Recruiting Parkinson's Disease Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer ClinicalTrials.gov Identifier: NCT00124930 - Recruiting Refractory Nausea Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting Pain An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting Analgesia

GoldBambooTM Your Integrative Health and Wellness Resource November 26, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.